VIROVEK'S

BAC-TO-AAV TECHNOLOGY
FOR LARGE SCALE AAV PRODUCTION

Virovek’s latest suicide gene therapy technology

Nanjing, China, April 25-27, 2013

Company CEO, Dr. Haifeng Chen, chaired the Gene Therapy session and presented Virovek’s latest suicide gene therapy technology using toxins to target cancer cells at the BIT’s 4th Annual World DNA and Genome Day (WDD-2013).